119 related articles for article (PubMed ID: 1497392)
21. A standard heparin nomogram for the management of heparin therapy.
Cruickshank MK; Levine MN; Hirsh J; Roberts R; Siguenza M
Arch Intern Med; 1991 Feb; 151(2):333-7. PubMed ID: 1789820
[TBL] [Abstract][Full Text] [Related]
22. Aging and heparin-related bleeding.
Campbell NR; Hull RD; Brant R; Hogan DB; Pineo GF; Raskob GE
Arch Intern Med; 1996 Apr; 156(8):857-60. PubMed ID: 8774204
[TBL] [Abstract][Full Text] [Related]
23. Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support.
Adatya S; Uriel N; Yarmohammadi H; Holley CT; Feng A; Roy SS; Reding MT; John R; Eckman P; Zantek ND
JACC Heart Fail; 2015 Apr; 3(4):314-22. PubMed ID: 25770404
[TBL] [Abstract][Full Text] [Related]
24. Activated partial thromboplastin time monitoring in patients receiving unfractionated heparin for venous thromboembolism in relation to clinical outcomes.
Vardi M; Laor A; Bitterman H
Thromb Haemost; 2009 Nov; 102(5):879-86. PubMed ID: 19888523
[TBL] [Abstract][Full Text] [Related]
25. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
Prandoni P; Carnovali M; Marchiori A;
Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
[TBL] [Abstract][Full Text] [Related]
26. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial.
Pini M; Pattachini C; Quintavalla R; Poli T; Megha A; Tagliaferri A; Manotti C; Dettori AG
Thromb Haemost; 1990 Oct; 64(2):222-6. PubMed ID: 2270531
[TBL] [Abstract][Full Text] [Related]
27. Rapid determination of maintenance heparin infusion rates with the use of non-steady-state heparin concentrations.
Kandrotas RJ; Gal P; Douglas JB; Groce JB
Ann Pharmacother; 1993 Dec; 27(12):1429-33. PubMed ID: 8305769
[TBL] [Abstract][Full Text] [Related]
28. Appropriate use of heparin. Empiric vs nomogram-based dosing.
Gunnarsson PS; Sawyer WT; Montague D; Williams ML; Dupuis RE; Caiola SM
Arch Intern Med; 1995 Mar; 155(5):526-32. PubMed ID: 7864708
[TBL] [Abstract][Full Text] [Related]
29. Physician practices in the treatment of pulmonary embolism and deep venous thrombosis.
Wheeler AP; Jaquiss RD; Newman JH
Arch Intern Med; 1988 Jun; 148(6):1321-5. PubMed ID: 3377615
[TBL] [Abstract][Full Text] [Related]
30. Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times.
Anand SS; Bates S; Ginsberg JS; Levine M; Buller H; Prins M; Haley S; Kearon C; Hirsh J; Gent M
Arch Intern Med; 1999 Sep; 159(17):2029-32. PubMed ID: 10510988
[TBL] [Abstract][Full Text] [Related]
31. Effect of warfarin on activated partial thromboplastin time in patients receiving heparin.
Kearon C; Johnston M; Moffat K; McGinnis J; Ginsberg JS
Arch Intern Med; 1998 May; 158(10):1140-3. PubMed ID: 9605787
[TBL] [Abstract][Full Text] [Related]
32. Laboratory control of continuous intravenous heparin therapy with Howel time and activated partial thromboplastin time. A prospective, randomized and blind study.
Almazan A; Lozano F; Ramos M; Rodriguez-Moran M; Gomez-Alonso A
Angiology; 1985 Jun; 36(6):363-9. PubMed ID: 4025944
[TBL] [Abstract][Full Text] [Related]
33. Shortened hospitalization by means of adjusted-dose subcutaneous heparin for deep venous thrombosis.
Hirsch DR; Lee TH; Morrison RB; Carlson W; Goldhaber SZ
Am Heart J; 1996 Feb; 131(2):276-80. PubMed ID: 8579021
[TBL] [Abstract][Full Text] [Related]
34. Review of the initiation of anticoagulant therapy.
Corbett NE; Peterson GM
J Clin Pharm Ther; 1995 Aug; 20(4):221-4. PubMed ID: 8557786
[TBL] [Abstract][Full Text] [Related]
35. Rethrombosis--warfarin or low-dose heparin?
Wessler S; Gitel SN
N Engl J Med; 1979 Oct; 301(16):889-91. PubMed ID: 384252
[No Abstract] [Full Text] [Related]
36. Weight-based heparin dosing: clinical response and resource utilization.
Lackie CL; Luzier AB; Donovan JA; Feras HI; Forrest A
Clin Ther; 1998; 20(4):699-710. PubMed ID: 9737830
[TBL] [Abstract][Full Text] [Related]
37. A comparison of high-dose versus conventional-dose heparin therapy for deep vein thrombosis.
Conti S; Daschbach M; Blaisdell FW
Surgery; 1982 Dec; 92(6):972-80. PubMed ID: 7147193
[TBL] [Abstract][Full Text] [Related]
38. Heparin therapy in venous thromboembolism.
Wilson JE; Bynum LJ; Parkey RW
Am J Med; 1981 Apr; 70(4):808-16. PubMed ID: 7211918
[TBL] [Abstract][Full Text] [Related]
39. Antithrombotic therapy in deep vein thrombosis and pulmonary embolism.
Hirsh J
Am Heart J; 1992 Apr; 123(4 Pt 2):1115-22. PubMed ID: 1553881
[TBL] [Abstract][Full Text] [Related]
40. Inadequacy of intravenous heparin therapy in the initial management of venous thromboembolism.
Lee HN; Cook DJ; Sarabia A; Hatala R; McCallum A; King D; Guyatt GH; Dobranowski J; Powers P
J Gen Intern Med; 1995 Jun; 10(6):342-5. PubMed ID: 7562125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
